Daniel C Rabe, PhD
Affiliations: | 2009-2011 | Urologic Oncology Branch | National Cancer Institue-NIH |
| 2017- | Harvard Medical School - Massachusetts General Hospital |
Google:
"Daniel Rabe"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Donald P Bottaro | research assistant | 2009-2011 | Harvard Medical School - Massachusetts General Hospital |
| Marsha Rich Rosner | grad student | Chicago (Cell Biology Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Shah MA, Wainberg ZA, Catenacci DVT, et al. (2022) Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer. Plos One. 17: e0276211 |
| Porter RL, Sun S, Flores MN, et al. (2022) Satellite repeat RNA expression in epithelial ovarian cancer associates with a tumor immunosuppressive phenotype. The Journal of Clinical Investigation |
| Shah MA, Wainberg ZA, Catenacci DVT, et al. (2021) Correction: Phase II Study Evaluating 2 Dosing Schedules of Oral Foretinib (GSK1363089), cMET/VEGFR2 Inhibitor, in Patients with Metastatic Gastric Cancer. Plos One. 16: e0261994 |
| Rabe DC, Walker ND, Rustandy FD, et al. (2021) Tumor Extracellular Vesicles Regulate Macrophage-Driven Metastasis through CCL5. Cancers. 13 |
| Lee J, Yesilkanal AE, Wynne JP, et al. (2019) Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism. Nature |
| Lee J, Yesilkanal A, Frankenberger C, et al. (2018) Abstract 5497: Effective combination therapy for breast cancer targeting BACH1 and mitochondrial metabolism Cancer Research. 78: 5497-5497 |
| Yesilkanal AE, Rabe DC, Tiwari P, et al. (2018) Abstract 4179: A novel approach for antimetastatic therapies against TNBC utilizing a physiologic suppressor Tumor Biology |
| Rabe DC, Lee J, Rustandy F, et al. (2018) Abstract 1739: Tumor extracellular vesicles are required for tumor-associated macrophage programming Immunology |
| Lee MM, Rabe DC, McKee TC, et al. (2018) Abstract A127: The identification and development of selective natural product inhibitors of hypoxia inducible factor-2α for the treatment of renal cell carcinoma Molecular Cancer Therapeutics. 17 |
| Bainer R, Frankenberger C, Rabe D, et al. (2016) Gene expression in local stroma reflects breast tumor states and predicts patient outcome. Scientific Reports. 6: 39240 |